Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2015-03-09
2017-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)
NCT03598400
Home-HIT and Type 1 Diabetes
NCT03545802
Compliance to HIT-program at Home With the Use of Technology
NCT03166852
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training
NCT04825366
Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b)
NCT06080542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIT training
6 weeks of high-intensity interval training (HIT)
HIT
Participants completed 6 weeks of HIT
Moderate intensity training
6 weeks of moderate-intensity continuous training (MICT)
MICT
Participants completed 6 weeks of MICT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIT
Participants completed 6 weeks of HIT
MICT
Participants completed 6 weeks of MICT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* basal bolus regimen
* no significant history of hyper- or hypoglycaemia (determined from medical history)
Exclusion Criteria
* insulin pump therapy
* significant history of hyper- or hypoglycaemia (determined from medical history)
* obesity (BMI \>30 kg∙m-2)
* pregnancy or planning pregnancy
* uncontrolled hypertension (\>180/100 mmHg)
* angina, autonomic neuropathy
* taking any medication that affects heart rate
* major surgery planned within 6 weeks of the study
* severe nonproliferative
* unstable proliferative retinopathy
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Liverpool John Moores University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sam Shepherd
Dr Sam Shepherd, Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liverpool John Moores University
Liverpool, Merseyside, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
T1D_PARTB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.